LRRK2 and Parkinson disease: In summary, using PD Drosophila, mice and hMLOs models, we demonstrated that LRRK2 mutations up-regulate TH expression and DA levels at the early stage of disease and this led to DA toxicity and facilitated DA neuron degeneration.